# AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

> **NCT03547635** · NA · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 116 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **OTHER:** AMNIOEXCEL Plus Amniotic Membrane
- **DEVICE:** A Marketed Comparator
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03547635
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2019-02-26
- **Final completion:** 2019-02-26
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2020-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547635, "AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03547635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*